Published peptide research references
Exendin-4
Governed registry record
3 approved source records with original-source links. Source verification confirms the reference and its connection to this record; it does not certify every scientific conclusion or establish safety or efficacy.
Approved source records
Exendin-4 Prevents oxLDL-Induced upregulation of TREM2 and attenuates foam cell formation and inflammation in Macrophages.
DOI: 10.1016/j.bcp.2025.117306
Source identity and connection checked by Codex (AI).
Exendin-4 analogs in insulinoma theranostics.
Source identity and connection checked by Codex (AI).
Harmine and exendin-4 combination therapy safely expands human β cell mass in vivo in a mouse xenograft system.
DOI: 10.1126/scitranslmed.adg3456
Source identity and connection checked by Codex (AI).
Legacy research context
Context from the legacy curated dataset. Its counts describe that dataset and are separate from the live approved source records above.
Researchers represented
- Rosselot C
- Li Y
- Wang P
- Alvarsson A
- Beliard K
- Lu G
- Kang R
- Li R
- Liu H
- Gillespie V
- Tzavaras N
- Kumar K
- DeVita RJ
- Stewart AF
- Stanley SA
- Garcia-Ocaña A
- Leung K
- Wang X
- Jiang M
- Bao H
- Huang R
- Chen B
- Wu C
- Wang H
- Luo Z
- Li W
- Jansen TJP
- van Lith SAM
- Boss M
- Brom M
- Joosten L
- Béhé M
- Buitinga M
- Gotthardt M